C
Christopher P. Johnson
Researcher at Royal Liverpool University Hospital
Publications - 151
Citations - 6974
Christopher P. Johnson is an academic researcher from Royal Liverpool University Hospital. The author has contributed to research in topics: Transplantation & Kidney. The author has an hindex of 38, co-authored 147 publications receiving 6653 citations. Previous affiliations of Christopher P. Johnson include Medical College of Wisconsin & University of Minnesota.
Papers
More filters
Journal ArticleDOI
Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996
Sundaram Hariharan,Christopher P. Johnson,Barbara A. Bresnahan,S. Taranto,Matthew McIntosh,Donald Stablein +5 more
TL;DR: There has been a substantial increase in short-term and long-term survival of kidney grafts from both living and cadaveric donors since 1988.
Journal ArticleDOI
Post-transplant renal function in the first year predicts long-term kidney transplant survival
Sundaram Hariharan,Maureen A. McBride,Wida S. Cherikh,Christine B. Tolleris,Barbara A. Bresnahan,Christopher P. Johnson +5 more
TL;DR: Recent improvements in graft half-life are related to conservation of renal function within the first year post-transplantation, and one-year creatinine and Delta Creatinine values predict long-term renal graft survival.
Journal ArticleDOI
Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
Christopher P. Johnson,Nasimul Ahsan,Thomas A. Gonwa,Philip F. Halloran,Mark D. Stegall,Mark A. Hardy,Robert A. Metzger,Charles F. Shield,Leslie L. Rocher,John D. Scandling,John Sorensen,Laura L. Mulloy,Jimmy A. Light,Claudia Corwin,Gabriel M. Danovitch,Michael Wachs,Paul VanVeldhuisen,K. Salm,D. Tolzman,William E. Fitzsimmons +19 more
TL;DR: All regimens yielded similar acute rejection rates and graft survival, but the tacrolimus + MMF regimen was associated with the lowest rate of steroid resistant rejection requiring antilymphocyte therapy.
Journal ArticleDOI
Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR).
Sundaram Hariharan,Mark B. Adams,Daniel C. Brennan,Connie L. Davis,M. Roy First,Christopher P. Johnson,Rosemary Ouseph,V. Ram Peddi,Corey J. Pelz,Allan M. Roza,Flavio Vincenti,Varghese George +11 more
TL;DR: There was no difference in the rate of recurrent and de novo disease according to the transplant type (living related donor vs. cadaver, P=NS), and demographic findings were not significantly different.
Journal ArticleDOI
Bacterial adherence to surgical sutures: can antibacterial-coated sutures reduce the risk of microbial contamination?
Charles E. Edmiston,Gary R. Seabrook,Michael P. Goheen,Candace J. Krepel,Christopher P. Johnson,Brian D. Lewis,Kellie R. Brown,Jonathan B. Towne +7 more
TL;DR: In this paper, the authors used a standardized in vitro microbiologic model to assess bacterial adherence and the antibacterial activity of a triclosan-coated polyglactin 910 (braided) suture against selected Gram-positive and Gram-negative clinical isolates that may infect surgical wounds.